Clinical Perspectives Presentation 8.3
Pharmacoepidemiological Studies of Second-Generation Antipsychotics and Risk of Type 2 Diabetes

Tuesday, October 22, 2013 1:00 PM
Tobias Gerhard, PhD, Rutgers University, New Brunswick, NJ
William V. Bobo, MD, MPH, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN
Mark Olfson, MD, MPH, Psychiatry, Columbia University, New York, NY
Stephen Crystal, PhD, Rutgers University, Princeton, NJ
See more of: Integrating Behavioral and Medical Findings from Studies Assessing Risk, Efficacy, Tolerability, and Safety for Children Receiving Antipsychotic Medications
See more of: Clinical Perspectives
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.